[Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
Atarashi
H
H
Iida
K
K
Kou
M
M
Hirayama
Y
Y
Gotoh
M
M
Ino
T
T
Katoh
T
T
Hayakawa
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004594:Electrophysiology; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline